Interleukin 1B genetic patterns predict life-long tendency to inflammation and related cardiovascular event...
Interleukin 1B genetic patterns predict life-long tendency to inflammation and related cardiovascular event risk profile
Interleukin Genetics, Inc. (AMEX:ILI), today announced publication of the results of clinical studies that support the company's Heart Health Genetic Test to assess cardiovascular risk. The article, titled, "IL1B Gene Promoter Haplotype Pairs Predict Clinical Levels of Interleukin-1β and C-reactive Protein," was published in the journal Human Genetics (123:387-398; May 2008) and further confirms prior studies associating variations in the Interleukin 1B (IL1B) gene with the inflammatory response.
To view Multimedia News Release, go to *******www.prnewswire****/mnr/ilgenetics/32863/